Carfilzomib With Bendamustine and Dexamethasone in Multiple Myeloma
Clinical trial NCT02002598 · TERMINATED
Trial details
- NCT number
- NCT02002598
- Sponsor
- Suzanne Lentzsch, MD
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2019-03-01
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.